The International Multidisciplinary Breast Conference 2019
 
SPEAKERS
Prof. Virgilio Sacchini MD
Attending Surgeon, Full Professor of Surgery
Breast Service of Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University in New York, New York, USA

Prof. Sacchini is a surgeon who specializes in the treatment of breast cancer. For the past ten years, He have been involved as a co-investigator in clinical trials in Milan, Italy, to evaluate conservative surgery and sentinel-node mapping in breast cancer. In Italy, Prof. Sacchini served as Deputy Director of the Breast Department in the European Institute of Oncology, a leading institution for the study and treatment of breast cancer. He was also a clinical coordinator of the Italian Breast Cancer Chemoprevention Study of Tamoxifen and a clinical investigator in breast cancer trials for the European Organization for Research and Treatment of Cancer (EORTC).
 
Dr. Atif Jalees Khan MD, MS
Radiation Oncologist
Memorial Sloan Kettering Cancer Center, New York, USA

Dr. Atif Khan is an Associate Attending Radiation Oncologist at the Memorial Sloan Kettering Cancer Center. Dr. Khan completed residency at the Rush University Medical Center in Chicago IL and a fellowship in brachytherapy at Harvard’s Brigham and Women's Hospital and was on the faculty of the Rutgers Cancer Institute of New Jersey before joining the Memorial Sloan Kettering Cancer Center. Dr. Khan treats patients with breast, central nervous system, and other tumors in his practice. He is a national expert on breast radiotherapy and leads major ongoing trials in this area, including NSABP B51 and Alliance A221505 and is on major national committees. He also serves as an oral examiner and an item-writer in the breast section for the American Board of Radiology, the certifying body for radiation oncology trainees in the Unites States.

 
Dr. Danijela Jelovac MD
Assistant Professor of Oncology
Johns Hopkins Hospital, Maryland, USA

Dr. Danijela Jelovac is an assistant professor of oncology with primary interest in women malignancies, particularly breast cancer and gynecological malignancies. Her clinical focus is on development of new approaches for prevention and treatment of breast and gynecologic malignancies. A member of the American Society of Clinical Oncology, Dr. Jelovac has published numerous peer-reviewed journal articles and book chapters and has presented her work at national meetings.

 
Dr. Hannah Yong Wen MD, PhD
Director, Breast Pathology Fellowship
Memorial Sloan Kettering Cancer Center, New York, USA

Dr. Hannah Yong Wen is an Associate Attending Pathologist, the director of Breast Pathology Fellowship, and the co-director of the Medical Donation Program at Memorial Sloan Kettering Cancer Center. Dr. Wen’s clinical practice is exclusively on the diagnosis of breast lesions. She received her MD degree from Peking University Health Science Center and PhD in Cancer Biology from MD Anderson Cancer Center. She completed residency training in Anatomic and Clinical Pathology at New York University Langone Medical Center, and Surgical Pathology and Breast Pathology fellowships at Memorial Sloan Kettering Cancer Center. Dr. Wen has authored 70 peer-reviewed publications, multiple invited reviews and book chapters, and has lectured at various nationally and international conferences and educational courses. Her current research is focused on the genomic alterations and tumor micro environment of triple negative breast cancer. She is a member of Memorial Sloan Kettering Cancer Center Research Council, an Elected Officer of International Society of Breast Pathology, and a member of NRG Oncology Breast Cancer Translational Subcommittee. She also serves as an ad hoc reviewer for numerous journals and an associate editor for BMC Cancer.

 
Dr. Jane Mendez MD
Chief of Breast Surgery
Miami Cancer Institute, Florida, USA

Dr. Jane Mendez is a breast surgical oncologist at Miami Cancer Institute. She specializes in the treatment of breast cancer and performs all types of breast surgical procedures. Dr. Mendez has contributed to notable breast cancer research and her findings have been widely published. She also has presented abstracts at numerous national and international symposiums and serves on the editorial board of the breast section of the Annals of Surgical Oncology, a commonly used resource. Renowned for her patient care and advocacy, Dr. Mendez is passionate about educating patients and advancing breast cancer awareness and prevention outside the hospital setting, in the community and at national meetings. She was appointed to the governing board of Susan G. Komen,

Massachusetts affiliate. She is a fellow of the American College of Surgeons and an active member of numerous professional societies, including the American Society of Breast Surgeons and the Society of Surgical Oncology.

 
Dr. Judy C. Boughey MD
General Surgeon
Mayo Clinic Cancer Center Clinical Researchers, Minnesota, USA

Dr. Judy C. Boughey is the professor of surgery at Mayo Clinic, vice chair for research in the Department of Surgery, medical director ofthe Surgical Clinical Research Office and program director of the Breast Surgery Fellowship. She is on the Board of Directors of the American Society of Breast Surgeons and Education Committee chair for the American College of Surgeons Clinical Research Programand author of over 180 peer-reviewed paper Dr. Judy C. Boughey is a passionate researcher and has led multiple national clinical trials; ACOSOG Z1071 evaluating SLN surgery in patients with node positive breast cancer treated with neoadjuvant chemotherapy, ACOSOG Z11102 evaluating breast conservation in women with multiple ipsilateral breast tumors and ALLIANCE A11202 comparing axillary dissection to axillary radiation for patients with node positive disease after neoadjuvant chemotherapy.

 
Dr. Mahmoud El Tamer MD
Oncoplastic Breast Surgeon, Surgical Oncology & Reconstruction
Memorial Sloan Kettering Cancer Center, New York, USA

Dr. Mahmoud El Tamer is trained as a breast surgeon with 25 years of experience caring for patients with breast cancer, and works collaboratively with other breast cancer specialists on Memorial Sloan-Kettering Cancer Center’s multidisciplinary breast cancer disease management team.

Dr. El-Tamer received his MD from the American University of Beirut in 1981. He completed his residency at the American University of Beirut Medical Center in 1985, followed by four years of surgical oncology and reconstructive surgery at Memorial Sloan-Kettering Cancer Center. After his training, Dr. El-Tamer became interested in joining these two disciplines to provide improved care to breast cancer patients, and has developed a special expertise in this growing field of oncoplastic surgery.

Dr. El-Tamer’s research interests have covered different aspects of breast cancer and quality of care in surgery. He has been the principal or co-principal investigator on research grants from the Avon Breast Cancer Foundation, the United States Veterans’ Administration, and the American College of Surgeons. His current research interests are focused on tumor micro-environment post mastectomy radiation in 1–3 positive nodes and breast conservation. Dr. El-Tamer has published “Principals & Techniques in Oncoplastic Breast Cancer Surgery”, a textbook to help other surgeons enhance cosmetic results while performing surgery to treat breast cancer. He is currently collaborating with international Oncoplastic surgeons to publish a second edition. Dr. El-Tamer holds the patent to a new agent for sentinel node detection.

 
Dr. Maroun El Khoury MD
Consultant Medical Oncologist
American Hospital, Dubai, UAE

Dr. Maroun El Khoury completed his basic medical training from Saint Joseph University School of Medicine Beirut, Lebanon in 1999. He completed his US Board Certification in Internal Medicine (2003) and both Oncology & Hematology in 2006. Prior to joining us, Dr. El Khoury was working since July, 2006 as an Attending Physician Hematology/Oncology at the Great River Hematology and Oncology Iowa USA. He also served as Medical Director & Chief of Medicine at the same place and co-directed the hospice and palliative care program. He is also a member of the American Society of Clinical Oncology, American Society of Hematology and American Academy of Pain Management.

 
Dr. Ming-Huei Cheng MD, MBA, FACS
President and Professor
Department of Plastic Reconstructive Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan

Dr. Ming-Huei Cheng attended Chung-Shan Medical College, graduating in 1988. After completing both his residency in general and plastic surgery with Chang Gung Memorial Hospital, Taoyuan, Taiwan, he worked as trauma plastic surgeon for 3 years and served as deputy chairman and professor of plastic and reconstructive surgery for over 10 years.

As a fellow of the American College of Surgery, a member of the American Society of Plastic Surgeons, and a member of the World Society for Reconstructive Microsurgery to name a few, some of his most outstanding accomplishments include: winning the 2006 Godina Travel Fellow, American Society for Reconstructive Microsurgery award, hosting the 2009 ASBPRS and the 2013 International Symposium for Surgical Treatment of Lymphedema conferences, publishing a sequence of books titled Breast: the comprehensive guideline in Mandarin (English in progress), lecturing in Singapore and over 10 states in the USA as visiting professor, mentoring and training over 60 visiting international fellows in the field of reconstructive microsurgery.

Today, Dr. Ming-Huei Cheng is listed among one of the most sought-after doctors/professors in the reconstructive microsurgery field. His innovative surgical methods as well as his unique techniques have gained him global recognition and praise, attracting innumerable medical scholars and patients alike from as close as Korea, Japan, Malaysia and Singapore, and far as North and South America, the Middle East and Europe.

 
Dr. Mohammed Jaloudi MD
Associate Professor of Medicine/Oncology
Rutgers Cancer Institute of New Jersey, Rutgers New Jersey Medical School, Newark, NJ, USA

I am currently back in my home state working as an Associate Professor of Medicine, Division of Hematology/Oncology at Rutgers New Jersey Medical School and the Cancer Institute of New Jersey.  Prior to this current appointment, I was Director of Medical Oncology at The AtlantiCare Cancer Care Institute, a Fox Chase Cancer Center affiliate since November of 2017. From February of 2006 until August of 2017, I was Chairman of The Oncology Department at Tawam Hospital in Al Ain, UAE.  Since the middle of 2006, Tawam Hospital has been managed in affiliation with Johns Hopkins Medicine International (JHMI).

Having worked in New York City during the beginning of my career, taking on a challenging role in the UAE was more rewarding than I could have imagined. As the world has become more intertwined and closer than ever before, one realizes that we are more similar than we think. Medicine is no different, though ethnic and cultural variations may exist. My area of interest has been in solid tumors with an emphasis on breast cancer. Having been instrumental in initiating collaborative groups and trials throughout the Middle East and Africa, I am hopeful this collaboration will continue across continents.

 
Dr. Rola Shaheen MD, FRCPC
Chief & Medical Director of Diagnostic Imaging
Peterborough Regional Health Center, Ontario, Canada

Dr. Rola Shaheen joins Health Centre from Abu Dhabi in January 2015 as Chief and Medical Director of Diagnostic Imaging (DI). Dr. Shaheen comes to Peterborough from her role as Chief of Women’s Imaging with Mafraq Hospital in Abu Dhabi, a major government hospital, where she worked to champion women’s health care issues, including planning initiatives for breast imaging services and interventions.

“I am passionate about the role radiology plays in a hospital setting,” says Dr. Shaheen. “Diagnostic imaging is not a commodity; it is an important, multidisciplinary clinical service that provides our patients with the answers they need. Just ten years ago, the technology and equipment were not what they are today. In my role with PRHC, I am dedicated to the pursuit of continuous education and quality improvement in everything we do.”

In addition to her recent work overseas, Dr. Shaheen has served as Chief of Radiology and Director of Women’s Imaging with Harrington Memorial Hospital, a community hospital affiliated with Harvard Medical School. She graduated from the Faculty of Medicine at Jordan University in Amman, followed by a year of medical school, an internship and a residency at the University of Toronto. Subsequent to her fellowship in women’s imaging with Harvard Medical School, she joined the faculty there for four years before she was recruited by the government of Abu Dhabi.

 
Dr. Sana Al Sukhun MD, MSc.
Director of Medical Oncology/ Hematology
President of Jordanian Oncology Society, Amman, Jordan

Dr. Sana Al Sukhun is a Consultant in Medical Oncology/Hematology, mainly interested in in translational research particularly development of biologic therapies and predictors of response to systemic therapy targeting breast, ovarian, and other solid tumors. In addition, my work focuses on advocating for greater awareness of cancer particularly breast cancer, its regional impact, and the importance of research to overcome cancer and improve access to proper health care.

In 2015, I was elected president of the Jordanian Oncology Society. I am Co-Chair of ASCO Resource Stratified Guideline Advisory Group and a past member of IAC. I am a member of the Global Policy Committee of ESMO, and an active member of various international societies. I served as Director of Breast and Gynecology Service at King Hussein Cancer Centre, and Assistant Professor of Medicine at the University of Jordan. I have represented Jordan in the MENA NCCN breast cancer committee. I have helped establish the National Breast Cancer Screening Guidelines Program in Jordan, contributed to the 2014 UICC Review of the WHO List of Essential Medicines for cancer, organized & chaired the first conference on Breast Cancer in Jordan mainly focusing on "Neoadjuvant therapy", introducing the concept in the region in 2004; the first “Women Oncology Conference”& "GI/GU Oncology Conference" in Jordan, chaired the scientific committees of several national and regional meetings; in addition to contributing as speaker and trainer to other regional conferences and workshops.

I have earned my medical degree from the University of Jordan, and pursued a Master of Science, majoring in cancer biology from Wayne State University (WSU) in Michigan. I completed internal medicine residency at Detroit Medical Centre, followed by postdoctoral research at WSU, while pursuing my fellowship in Medical Oncology & Hematology at Barbara Ann Karmanos Cancer Institute at WSU. I am board certified in medical Oncology & hematology.

 
Dr. Souzan El-Eid MD, FACS
Clinical Assistant Professor
University of Nevada, Nevada, USA

Dr. Souzan El-Eid is a breast surgeon with Comprehensive Cancer Centers of Nevada (CCCN) and serves as the Medical Director of the Breast Care Center at Summerlin Hospital. Dr. El-Eid is currently the Cancer Liaison Physician for the Cancer Program and co-chair of the Breast Tumor Board as well as Cancer Committee at Summerlin Hospital. She is an Adjunct Associate Professor of General Surgery at Touro University Nevada and has served as principal investigator for several clinical research studies.

Dr. El-Eid is past President of Clark County Medical Society and an instructor at the American Society of Breast Surgeons’ Annual Meeting, teaching Breast Ultrasound and Stereotactic Breast Biopsy. She was also invited by the American Society of Clinical Oncology (ACSO) to review and publish clinical practice guidelines on surgical margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer. The data was published by the Journal of Clinical Oncology in spring 2014. Additionally, Dr. El-Eid serves on various medical and imaging committees, co-authors numerous publications about breast cancer and breast diseases and frequently gives presentations and lecturers about breast cancer to the public and physicians.

Dr. El-Eid has been named Top Doctor by Vegas Seven and Desert Companion, Medical Marvels by Nevada Business Magazine, Distinguished Women in Nevada by Distinguished Publishing Company, Top Breast Surgeon by HealthTap, and America’s Most Compassionate Doctor as chosen by PatientsChoice.org. She has been recognized as Top Surgeon from Consumers’ Research Council of America and received the Cancer Liaison Physician, Outstanding Performance Award from the American College of Surgeons in 2006. Dr. El-Eid practices by her core philosophy, “The patient always comes first, all else is secondary.”